tradingkey.logo

Caris Life Sciences Inc

CAI

28.510USD

+0.990+3.60%
Horário de mercado ETCotações atrasadas em 15 min
7.92BValor de mercado
PerdaP/L TTM

Caris Life Sciences Inc

28.510

+0.990+3.60%
Mais detalhes de Caris Life Sciences Inc Empresa
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Informações da empresa
Código da empresaCAI
Nome da EmpresaCaris Life Sciences Inc
Data de listagemJun 18, 2025
Fundado em2020
CEOMr. David Dean Halbert
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 18
Endereço750 West John Carpenter Freeway
CidadeIRVING
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal75039
Telefone18667718946
Sitehttps://www.carislifesciences.com/
Código da empresaCAI
Data de listagemJun 18, 2025
Fundado em2020
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
526.22K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Vijay Mohan
Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Nathan Burns
Nathan Burns
Independent Director
Independent Director
--
--
Ms. Laura I. Johansen
Ms. Laura I. Johansen
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
526.22K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Vijay Mohan
Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: seg, 28 de jul
Atualizado em: seg, 28 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Halbert (David D)
44.22%
Sixth Street Partners, LLC
8.34%
J.H. Whitney Capital Partners, LLC
7.29%
Castleman Peter M
3.73%
Millennium Management LLC
1.29%
Other
35.13%
Investidores
Investidores
Proporção
Halbert (David D)
44.22%
Sixth Street Partners, LLC
8.34%
J.H. Whitney Capital Partners, LLC
7.29%
Castleman Peter M
3.73%
Millennium Management LLC
1.29%
Other
35.13%
Tipos de investidores
Investidores
Proporção
Individual Investor
49.04%
Investment Advisor
10.07%
Private Equity
7.29%
Hedge Fund
1.29%
Investment Advisor/Hedge Fund
0.51%
Other
31.81%
Participação acionária institucional
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
18
185.77M
66.84%
+183.22M
2025Q2
18
185.77M
66.84%
+183.22M
2025Q1
3
2.55M
0.92%
+2.55M
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Halbert (David D)
122.91M
44.22%
+120.52M
+5055.47%
Jun 18, 2025
Sixth Street Partners, LLC
25.64M
9.22%
+25.64M
--
Jun 18, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.29%
+20.26M
--
Jun 18, 2025
Castleman Peter M
10.37M
3.73%
+10.34M
+32049.87%
Jun 18, 2025
Millennium Management LLC
3.58M
1.29%
+3.58M
--
Jun 17, 2025
Halbert (Jon S.)
1.35M
0.49%
+1.22M
+920.73%
Jun 18, 2025
Poste (George H)
526.22K
0.19%
+526.22K
--
Jun 18, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI